NSD2 and Miyoshi myopathy: Although the specific E3 ligase responsive to phosphorylation of NSD2 in MM remains unidentified, breast cancer 1 (BRCA1) was found to act as an E3 ligase to support NSD2 degradation in the human myelogenous leukemia cell line K56298.